Management of comorbid bipolar disorder and alcohol dependence;Prise en charge de la comorbidité du trouble bipolaire avec l'alcoolodépendance

Presse Medicale

Volumn 37, Issue 7-8, 2008, Pages 1132-1137

  Brousse, Georges ^a   Garay, Ricardo P ^b   Benyamina, Amine ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Universite Paris Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; HALOPERIDOL; LITHIUM; OLANZAPINE; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANTICONVULSANT ACTIVITY; BIPOLAR DISORDER; CLINICAL FEATURE; COMORBIDITY; DRUG EFFICACY; DRUG TOLERANCE; FREQUENCY ANALYZER; HUMAN; LIFESPAN; MANIC DEPRESSIVE PSYCHOSIS; MOOD DISORDER; PREVALENCE; PSYCHOEDUCATION; PSYCHOTHERAPY; RISK FACTOR; SHORT SURVEY; SOCIOTHERAPY; STATISTICAL SIGNIFICANCE; WITHDRAWAL SYNDROME;

ALCOHOL-RELATED DISORDERS; ALCOHOLISM; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; GABA AGENTS; HUMANS; MOOD DISORDERS; VALPROIC ACID;

EID: 45649084957     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.09.020     Document Type: Short Survey

References (49)

1. Brown E.S. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 67 Suppl. 7 (2006) 24-30
2. Kahn JP. Comorbidités et troubles bipolaires Encephale. 2006;32:S511-S514.
3. Levin F.R., and Hennessy G. Bipolar disorder and substance abuse. Biol Psychiatry 56 (2004) 738-748
4. Ostacher M.J., and Sachs G.S. Update on bipolar disorder and substance abuse: recent findings and treatment strategies. J Clin Psychiatry 67 (2006) e10
5. Salloum I.M., and Thase M.E. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2 (2000) 269-280
6. Salloum I.M., Cornelius J.R., Daley D.C., Kirisci L., Himmelhoch J.M., and Thase M.E. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62 (2005) 37-45
7. Kessler R.C., Crum R.M., Warner L.A., and Nelson C. Lifetime co-occurrence of DSMIII- R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54 (1997) 313-321
8. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 (1990) 2511-2518
9. Alonso J., ESEMeD/MHEDEA 2000 Investigators, and European Study of the Epidemiology of Mental Disorders and Project. E. 12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 420 (2004) 28-37
10. Frye M.A., Altshuler L.L., McElroy S.L., Suppes T., Keck P.E., Denicoff K., et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 160 (2003) 883-889
11. Pickering P. Conduites d'alcoolisation et pathologies psychiatriques. In: Reynaud M. (Ed). Traité d'addictologie (2006), Flammarion (Médecine Sciences), Paris 340-349
12. Brady K.T., and Sonne S.C. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 56 Suppl. 3 (1995) 19-24
13. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50 (1998) 143-151
14. Brousse G., Boussiron D., and Llorca P.M. Trouble bipolaire et alcoolisme : une association qui n'est pas fortuite. Rev Fr Psychiatr Psychol Med 7 (2003) 51-54
15. Salloum I.M., Cornelius J.R., Mezzich J.E., Kirisci L., Daley D.C., Spotts C.R., et al. Characterizing female bipolar alcoholic patients presenting for initial evaluation. Addict Behav 26 (2001) 341-348
16. Comtois K.A., Russo J.E., Roy-Byrne P., and Ries R.K. Clinicians' assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients. Biol Psychiatry 56 (2004) 757-763
17. Sonne S.C., and Brady K.T. Substance abuse and bipolar comorbidity. Psychiatr Clin North Am 22 (1999) 609-627
18. Book S.W., and Myrick H. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs 14 (2005) 371-376
19. Vornik L.A., and Brown E.S. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 67 (2006) 24-30
20. Hasin D.S., Trautman K.D., Miele G.M., Samet S., Smith M., and Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 153 (1996) 1195-1201
21. Société Française d'Alcoologie, Agence nationale d'accréditation et d'évaluation en santé (Anaes). Conférence de consensus 1999 - Objectifs, indications et modalités du sevrage du patient alcoolodépendant. Alcoologie et Addictologie 21 2S (1999) 1S-220S
22. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders, 2nd edition, 2006. www.psychorg/psych_pract/treatg/pg/prac_guidecfm.
23. Bowden C.L. Predictors of response to divalproex and lithium. J Clin Psychiatry 56 Suppl. 3 (1995) S25-S30
24. Dilsaver S.C., Swann A.C., Shoaib A.M., and Bowers T.C. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. J Psychiatry Neurosci 18 (1993) 61-66
25. McElroy S.L., Keck P.E., Pope H.G., Hudson J.I., Faedda G.L., and Swann A.C. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 149 (1992) 1633-1644
26. Dorus W., Ostrow D.G., Anton R., Cushman P., Collins J.F., Schaefer M., et al. Lithium treatment of depressed and non-depressed alcoholics. JAMA 262 (1989) 1646-1652
27. Brady K.T., Myrick H., Henderson S., and Coffey S.F. The use of divalproex in alcohol relapse prevention: a pilot study. Drug Alcohol Depend 67 (2002) 323-330
28. Huguelet P., and Morand-Collomb S. Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse. Pharmacol Res 52 (2005) 392-394
29. Johnson B.A., Ait-Daoud N., Bowden C.L., DiClemente C.C., Roache J.D., Lawson K., et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361 (2003) 1677-1685
30. Le Fauve C.E., Litten R.Z., Randall C.L., Moak D.H., Salloum I.M., and Green A.I. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol Clin Exp Res 28 (2004) 302-312
31. Mueller T.I., Stout R.L., Rudden S., Brown R.A., Gordon A., Solomon D.A., et al. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 21 (1997) 86-92
32. Davis L.L., Ryan W., Adinoff B., and Petty F. Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol 20 (2000) S1-S17
33. Reoux J.P., Saxon A.J., Malte C.A., Baer J.S., and Sloan K.L. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res 25 (2001) 1324-1329
34. Brady K.T., Sonne S.C., Anton R., and Ballenger J.C. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 56 (1995) 118-121
35. Albanese M.J., Clodfelter R.C., and Khantzian E.J. Divalproex sodium in substance abusers with mood disorder. J Clin Psychiatry 61 (2000) 916-921
36. Myrick H., and Brady K.T. The use of divalproex in the treatment of addictive disorders. Psychopharmacol Bull 37 Suppl. 2 (2003) 89-97
37. Calabrese J., Shelton M., Elhaj O., Rapport D., Youngstrom E., Packer K., et al. P.5.030 Substance use disorders and their treatment response in dual diagnosis bipolar disorder. Eur Neuropsychopharmacol 13 (2003) S419-S420
38. Calabrese J.R., and Delucchi G.A. Phenomenology of rapid cycling manic depression and its treatment with valproate. J Clin Psychiatry 50 Suppl. (1989) 30-34
39. Dreifuss F.E., and Langer D.H. Hepatic considerations in the use of antiepileptic drugs. Epilepsia 28 Suppl. 2 (1987) S23-S29
40. Dreifuss F.E., Santilli N., Langer D.H., Sweeney K.P., Moline K.A., and Menander K.B. Valproic acid hepatic fatalities: a retrospective review. Neurology 37 (1987) 379-385
41. Kalapos M.P. Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events: Retrospective review of old data and call for new investigation. Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews) 21 (2002) 123-141
42. Goldstein B.I., Diamantouros A., Schaffer A., and Naranjo C.A. Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders. Drugs 66 (2006) 1229-1237
43. Modell J.G., Mountz J.M., Glaser F.B., and Lee J.Y. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol Clin Exp Res 17 (1993) 234-240
44. Guardia J., Segura L., Gonzalvo B., Iglesias L., Roncero C., Cardus M., et al. A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder. Alcohol Clin Exp Res 28 (2004) 736-745
45. Bhanji N.H., Chouinard G., Hoffman L., and Margolese H.C. Seizures, coma, and coagulopathy following olanzapine overdose. Can J Psychiatry 50 (2005) 126-127
46. Deshauer D., Albuquerque J., Alda M., and Grof P. Seizures caused by possible interaction between olanzapine and clomipramine. J Clin Psychopharmacol 20 (2000) 283-284
47. Camacho A., and Akiskal H.S. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers. J Affect Disord 85 (2005) 217-230
48. Frye M.A., and Salloum I.M. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disord 8 (2006) 677-685
49. McElroy S.L. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry 65 Suppl. 15 (2004) 35-44